toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Mercatelli, N., Galardi, S., & Ciafre, S. A. (2017). MicroRNAs as Multifaceted Players in Glioblastoma Multiforme. Int Rev Cell Mol Biol, 333, 269–323.
toggle visibility
Roh, T. H., Park, H. H., Kang, S. - G., Moon, J. H., Kim, E. H., Hong, C. - K., et al. (2017). Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis. Medicine (Baltimore), 96(27), e7422.
toggle visibility
Rosager, A. M., Sorensen, M. D., Dahlrot, R. H., Boldt, H. B., Hansen, S., Lathia, J. D., et al. (2017). Expression and prognostic value of JAM-A in gliomas. J Neurooncol, .
toggle visibility
Voss, D. M., Spina, R., Carter, D. L., Lim, K. S., Jeffery, C. J., & Bar, E. E. (2017). Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression. Sci Rep, 7(1), 4292.
toggle visibility
Gravina, G. L., Mancini, A., Colapietro, A., Vitale, F., Vetuschi, A., Pompili, S., et al. (2017). The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models. Tumour Biol, 39(6), 1010428317695528.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print